Education

Hepatitis C in Drug and Alcohol Settings
free training to support your role in curing hepatitis C!

Synopsis

People who inject drugs represent approximately 90% of newly acquired hepatitis C (HCV) infections. This course aims to provide practitioners working in Drug and Alcohol settings with the skills and knowledge to diagnose HCV, manage comorbidities and treat HCV.

Hurry! it starts on November 6 2020
This course will be delivered in threeparts:
Part 1 — a 1.5-hour eLearning component to be completed before the online session
Part 2 — a facilitated online Zoom session building on the eLearning content through interactive
case study discussions facilitated in small groups
Part 3 — an HCV Capacity Strengthening Toolkit provided at the end of the training
Find out more. Click HERE.

DANA is delighted to bring you access to selected WOWS12  presentations. Click the title to download:

• Failure to Decline: Older Australians and Alcohol  Dr Sarah Callinan Epidemiologist, Centre for alcohol policy research, Latrobe University
• Queensland Drug and Alcohol Court (QDAC) Always a Work in Progress Siobhán Delgado, Senior Social Worker with Queensland Drug and Alcohol court (QDAC)
• Painful Ageing: Opioids, Benzodiazepines and Other Drugs in Older People Professor Brian Draper, Professor (Conjoint) School of Psychiatry, University of NSW, Sydney 
•   Leading Change Through Collaboration Dr Tyler Okimoto, Associate Professor in Management, The University of Queensland  
•   Mindset – Obstacle or Opportunity? Jane Stanfield – Health Service Improvement Coach
• Fetal Alcohol Spectrum Disorder in Adults  Dr Haydn Till, Senior Neuropsychologist, Women’s and Childs Health Services, Gold Coast Health

From our colleagues at ASHM, a DANA partnering organisation.

ONLINE LEARNING FOR NURSES AVAILABLE: Nurses have a significant role to play in the elimination of stigma and discrimination experienced by people with blood borne viruses accessing health care.

ACCESS the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine’s ‘Removing Barriers: Providing Care for People with BBVs’ online learning module which will provide nurses with a greater understanding of BBVs, the impact of stigma and discrimination, and help identify opportunities to change practice and policy to reduce stigma and discrimination experienced by people living with BBVs.

ENROL at http://removingbarriers.ashm.org.au/how/

The Australasian Hepatology Association (AHA) is the peak professional body supporting and educating hepatology nurses and other health professionals across Australia and New Zealand.
Their one-day course will be held in Darwin, Adelaide, Melbourne and  Brisbane during November and December.
The AHA advises that their course is particularly useful for Drug and Alcohol Nurses.

Click here for full details.

Being held in Brisbane on July 24^th, this workshop provides a  great opportunity for an update on smoking cessation.

You can access the program at this Program 24 July Smoking Cessation Workshop

You can visit the website to register at this link 

The Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) are pleased to offer webinar access to selected education seminars from the Kirby Institute Seminar Series in June 2018.

Enhancing liver disease screening and hepatitis C treatment uptake among people who inject drugs

Alison Marshall
Postdoctoral Fellow, Viral Hepatitis Clinical Research Program, Kirby Institute
1:00pm – 2:00pm AEST   Tuesday 19 June 2018

ABSTRACT
To achieve WHO’s hepatitis C virus (HCV) elimination targets by 2030, liver disease assessment and treatment uptake among people who inject drugs (PWID) will need to be substantially increased globally. Enhanced knowledge of the remaining barriers to HCV-related care at the patient, provider, and system levels is thus a necessity. This seminar will present evidence from the LiveRLife cohort – a healthy liver campaign targeted to PWID who attend drug and alcohol centres in New South Wales, Australia – highlighting remaining gaps in HCV and liver disease knowledge among PWID, including PWID understanding of liver disease assessment results (i.e. transient elastography score). This seminar will also speak to system-level barriers, namely, restrictions for accessing reimbursed direct-acting antiviral therapies (DAAs) in Canada and Europe (e.g. drug and alcohol use restrictions) with implications for PWID populations specifically.

Go to the event page

Register here

Older people face specific issues in relation to problematic substance use. Demography and a growing ageing population make understanding these ever more important. But older people’s problems tend to be more invisible, both in care services and in substance use services.

This (free) online course brings these issues together from a health, social care, informal carer and public health point of view. It draws on international perspectives from experts in the UK, New Zealand, Australia and the USA, to compare and share knowledge, skills and best practice with the community.

Find out more here.

You are invited to a live online webinar!

Professor Robert Gish, from the USA,  will be presenting a case-study based program, that will discuss both practical and clinical considerations associated with managing the patient with Hepatitis C on OST therapy.

Wednesday 13th September 2017

NSW/TAS/ACT/QLD/VIC: 7.30pm – 9.00pm
SA/NT: 7.00pm – 8.30pm
WA: 5.30pm – 7.00pm

To take part in this webinar  register  at this link.

The password for the event is: spreadthecure

Do you see patients who inject drugs? You are invited to attend a free workshop, developed by the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) and the Kirby Institute.

People who inject drugs represent approximately 90% of newly acquired hepatitis C infections. Clinicians working with people who inject drugs play an important role in improving the health outcomes of people living with hepatitis C, and can reduce a patient’s risk of developing advanced liver disease.

The Hepatitis C in Drug and Alcohol Settings Education Program is designed to strengthen the capacity of healthcare professionals to effectively test for, treat and manage HCV infection. This session has been developed in collaboration with drug and  alcohol clinicians, hepatology specialists, GPs, nurses and representatives from drug user community organisations.

This free CPD activity is running in a number of locations across Australia, including:

Perth, WA              –   Date: Saturday 24 June 2017 Time: 8:30am-5:00pm

Brisbane, QLD      –  Date: Saturday 29 July 2017 Time: 8:30am-5:00pm

Macksville, NSW  – Date: Saturday 5 August 2017   Time:9:30am-4:30pm

Lidcombe, NSW   –  Date: Saturday 12 August 2017 Time: 8:30am-5:00pm

Canberra, ACT     –  Date: Sunday 5 November 2017 Time: 8:30am-5:00pm

This is a highly interactive course available for nurse practitioners, GPs, addiction medicine specialists and other clinicians able to prescribe. The program includes both online learning and a face-to-face workshop. Click on the links above for more information and to register.

All workshops are free and morning tea, lunch and afternoon tea will be provided. Travel scholarships are available for regional/rural practitioners.

Click here to visit the ASHM website.